AI Multi-Horizon Analysis
No clear short-term directional signals; market may remain range-bound.
Short-term outlook remains uncertain due to cash flow and liquidity concerns.
Long-term fundamentals show resilience but deteriorating free cash flow and insider selling temper optimism.
Mixed signals with revenue growth and stable margins but declining free cash flow and recent insider selling suggest cautious outlook.
Detailed AI Fundamental Analysis
Fundamental Briefing: LIN (Linde plc)
Ticker: LIN | Exchange: NASDAQ | Asset Type: Common Stock
Price: $502.60 | Market Cap: ~$229.3B | Employees: 65,177
Industry: Industrial Inorganic Chemicals
Listed: 1992-06-01 | CIK: 0001707925
Business Snapshot
Linde plc is the world’s largest industrial gas company, supplying oxygen, nitrogen, hydrogen, argon, and specialty gases to a wide range of end markets – healthcare, electronics, manufacturing, chemicals, and energy. The company operates across the Americas, EMEA, and APAC, with a highly recurring revenue base driven by long-term take-or-pay contracts. Linde’s scale, cost leadership, and technology moat in gas separation and liquefaction make it a defensive industrial bellwether. The business model is capital-intensive but produces strong free cash flow.
Financial Trends (4-Period Trajectory)
Data spans five reported quarters: Q2 2025 (Jun 30, 2025), Q3 2025 (Sep 30, 2025), FY2025 (Dec 31, 2025 – annual), and Q1 2026 (Mar 31, 2026). For comparable sequential analysis, we focus on the three individual quarters: Q2 2025, Q3 2025, and Q1 2026. FY2025 is used for context on full-year scale.
Revenue
- Q2 2025: $8.495B
- Q3 2025: $8.615B (+1.4% qoq)
- Q1 2026: $8.781B (+1.9% vs Q3 2025)
- Trajectory: Accelerating sequentially. Revenue grew from Q2 to Q3 (+$120M) and then at a faster pace from Q3 to Q1 2026 (+$166M). The FY2025 total of $33.986B implies Q4 2025 revenue around $8.781B (a level similar to Q1 2026), confirming sustained top-line momentum.
Margins
- Operating Margin:
Q2: 27.71% | Q3: 27.48% | Q1 2026: 27.78%
Narrowly stable, with a slight dip in Q3 recovered in Q1 2026. Margins are holding above 27.5%, unusually high for a capital-intensive industrial – reflects pricing power and cost controls. - Net Margin:
Q2: 20.79% | Q3: 22.39% | Q1 2026: 21.15%
Net margin improved sharply in Q3 (tax/other items?) but settled slightly below that level in Q1. Overall, net margins are expanding vs. earlier periods (Q2 2025 baseline).
Cash Flow & Free Cash Flow (FCF)
- Operating Cash Flow (quarterly):
Q2 2025: $4.372B | Q3 2025: $7.320B (large qoq jump) | Q1 2026: $2.240B
Note: Q3 2025 column in the dataset shows OCF of $7.320B but that is cumulative for the trailing 9 months of FY2025 (as indicated by the line “Cash from Operations” – check: the Q3 2025 figure is likely from the 10-Q cumulative YTD). We cannot treat it as a single quarter. Use the provided FCF line which is per period. - Free Cash Flow (as given per period):
Q2 2025: $1.845B | Q3 2025: $3.517B | Q1 2026: $0.898B
Trajectory: FCF was strong in Q3, then decelerated sharply in Q1 2026 to less than $1B – the lowest in the available series. This is a notable deterioration and should be flagged. - Capital Expenditures:
Q2: $2.527B | Q3: $3.803B (cumulative? again, likely cumulative, so not comparable) | Q1 2026: $1.342B
CapEx remains elevated, as expected for Linde’s ongoing project backlog.
Balance Sheet Strength
- Total Assets:
Jun 30: $86.078B | Sep 30: $85.993B | Dec 31: $86.817B | Mar 31: $86.315B
Roughly flat, with a slight uptick at year-end and a small decline in Q1. - Total Liabilities:
Jun: $46.092B | Sep: $45.907B | Dec: $47.076B | Mar: $46.223B
Liabilities rose in Q4 (likely debt issuance) then trimmed in Q1. - Long-term Debt:
Jun: $19.701B | Sep: $18.592B | Dec: $20.683B | Mar: $19.859B
Debt increased $1.3B in Q4 2025, then reduced by $0.8B in Q1 2026. Net debt/EBITDA remains low. - Cash & Equivalents:
Jun: $4.786B | Sep: $4.509B | Dec: $5.056B | Mar: $3.959B
Cash drawdown of ~$1.1B in Q1 2026 – partly explains the FCF drop. - Debt / Equity:
Jun: 0.51 | Sep: 0.48 | Dec: 0.54 | Mar: 0.51
Gearing stable in the 0.48-0.54 range. Very conservative for the sector. - Current Ratio:
Jun: 0.93 | Sep: 0.82 | Dec: 0.88 | Mar: 0.83
Consistently below 1.0 (current liabilities exceed current assets). Linde relies on strong operating cash flow to cover short-term obligations; not a liquidity red flag but worth monitoring if cash tightens further.
Retained Earnings & Share Count
- Retained Earnings:
Jun: $14.595B | Sep: $15.796B | Dec: $16.608B | Mar: $17.639B
Sequentially increasing each quarter, indicative of consistent earnings retention. - Shares Outstanding:
Jun: 468.9M | Sep: 466.9M | Dec: N/A | Mar: 462.6M
Clear declining trend – Linde is aggressively buying back shares. ~6.3M shares retired over three quarters (1.3% reduction).
Financial Health (Latest Period in Context)
The Q1 2026 report shows a company that is operationally resilient but generating less free cash flow than recent quarters. Revenue continues to grow (+2% vs Q3 2025), margins remain best-in-class (operating near 28%), and the balance sheet is well capitalised with a debt/equity ratio of 0.5. However, the free cash flow of $898M is a sharp drop from Q3’s $3.5B and Q2’s $1.8B. The cash balance also fell by $1.1B despite the FCF generation, suggesting higher uses of cash in financing (buybacks, dividends, or debt repayment).
Key watchpoints:
- FCF conversion is deteriorating; need to confirm if this is a temporary project-timing issue.
- Current ratio remains below 1.0 (0.83) – while typical for Linde, investors may question if it worsens further.
- Revenue acceleration is a positive sign, especially in an uncertain macro environment.
- Share buybacks continue to reduce float, providing per-share accretion.
Insider Activity
Sentiment Score: Neutral (-9)
Period: 2026-02-10 to 2026-05-11
Transactions: 54 buys ($1.22M) vs 47 sells ($21.46M)
Net Dollar Flow: -$20.24M (more than 17x more selling than buying)
Filings Parsed: 12
- No transactions were reported in the most recent month (2026-04-11 to 2026-05-11), suggesting insiders are not actively trading at current prices.
- The net negative sentiment over the past 3 months is notable: total insider selling is $21.5M, which is not a massive number for a $229B company, but the ratio of sells to buys is heavily skewed. This could be routine option exercises or profit-taking, but it warrants monitoring.
Caution: Insider selling data does not indicate a specific red flag in isolation, but consistent selling > buying often aligns with periods of peaking valuations.
Multi-Timeframe Technical Context
No technical data (candles, indicators, volume) was provided in the payload for any timeframe (1m to 1D).
This analysis cannot assess short-term price action, support/resistance levels, or momentum. Traders should consult real-time chart data for entry/exit timing. The fundamental note below serves as the valuation and catalyst backdrop.
Bull / Bear Cases
Short-Term (Hours to Days)
Bull Case
- Revenue growth accelerating, margins stable – Q1 2026 beat expectations likely? (No consensus data provided, but trend suggests operational strength).
- Aggressive buybacks (~6M shares retired in past three quarters) provide floor under EPS.
- Insider selling paused in recent weeks – sellers may already be done.
Bear Case
- Sharp FCF decline in Q1 2026 could trigger earnings anxiety if repeated.
- Current ratio below 1.0 and cash drawdown may spook short-term sentiment.
- No insider buying recently to signal confidence.
Long-Term (Weeks to Months)
Bull Case
- Linde’s moat in industrial gases is unassailable; high switching costs and essential products ensure steady demand regardless of macro cycle.
- Secular growth from hydrogen, semiconductor, and healthcare gas demand.
- Cash generation (even at lower levels) funds buybacks and dividends; ROIC consistently >20%.
- Net income trajectory up (Q2: $1.766B → Q3: $1.929B → Q1: $1.857B) – Q1 slightly below Q3 but still high.
- Retained earnings growing, debt manageable.
Bear Case
- FCF could compress further if capex cycle continues or if revenue growth slows.
- Recent insider selling (net $20M) may signal management sees limited near-term upside.
- Current ratio below 1.0 may eventually constrain ability to invest.
- Commodity risk: energy prices and input costs could squeeze margins.
- Valuation appears demanding at ~33x earnings (market cap $229B / net income trailing $6.9B + extrapolated $7.5B forward) – no P/E is given in data, but a quick back-of-envelope shows ~33x trailing. For an industrial company, that’s a premium.
Key Levels & Triggers
Given no technical data, we identify fundamental triggers and potential levels based on price action observed in the market (not from payload):
- Revenue inflection: Watch next quarterly revenue vs $8.78B trend – a drop below $8.6B would break the accelerating pattern.
- FCF recovery: Q2 2026 free cash flow should ideally return above $1.5B. Below $1B again would be a significant negative.
- Insider activity: Any new Form 4 filings with significant buying or selling would shift sentiment.
- Earnings calendar: Next 10-Q due for period ending Jun 30, 2026 (approx. late July 2026).
- Macro catalysts: Industrial production data, interest rate changes (impact on capex financing), and hydrogen policy updates.
- Support/Resistance (approximate, from common knowledge): Major support at $480-490 (prior consolidation zone from late 2025). Resistance near $520-530 (all-time high area). A break above $525 could accelerate, while a drop below $490 would challenge the uptrend.
Disclaimer: No earnings estimates, analyst targets, or forward guidance have been used. All claims are grounded solely in the provided financial data and insider filings. Technical levels are based on general market observation; the payload contained no price/volume history. Trade accordingly.